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1. Introduction 
Diabetes mellitus is a serious metabolic disease and an important medical, social and 
economic problem globally. Long-term untreated hyperglycaemia – the main cause of a 
carbohydrate, lipid and osmotic imbalance – affects all tissues and organs in the body and 
leads to development of typical disease manifestations such as polydipsia, polyuria and 
polyphagia. This metabolic imbalance initiates other tissue and organ complications, some 
of which are extremely serious vasculopathies, cardiovascular diseases, neuropathies, 
myopathies, eye complications, renal complications and deteriorated regeneration and 
healing of wounds (Ceriello, 2005). 
The basic etiopathogenetic mechanism in diabetes mellitus is either a real lack of insulin 
(type 1) or a biological lack of insulin (type 2) arising from its peripherally changed 
utilization and subsequent insufficiency. Insulin is a polypeptide produced by beta-cells of 
the pancreas and is necessary for glucose metabolism, keeping the glucose level in the blood 
within values of 4 – 6 mmol/1 ml. Glucose is metabolized in all tissues and is the main 
energy source in the organism. Lack of insulin causes hyperglycaemia and unmetabolised 
glucose is excreted mostly by the kidneys. This state leads to the development of polyuria, 
requiring increased intake of liquids and food and causing tissues to metabolise other 
sources of energy (fats, proteins) much more. Insufficient effectiveness of insulin means the 
energy requirements of the organism are not fulfilled; the organism searches for additional 
energy sources, mainly for proteins and fats. Increased metabolism of fats leads to excretion 
of so-called keto-compounds by the kidneys accompanied by a typical smell which can be 
detected in the patient’s breath and sweat. 
Nowadays we divide diabetes mellitus into the insulin-dependent type 1 DM, also called 
children’s or adolescent DM, which presents an absolute lack of insulin caused by the 
autoimmune destruction of pancreatic beta-cells; and type 2 DM, which is known as adult 
diabetes, is a more frequent form of this illness and runs without clinical symptoms for a 
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longer time. The initial stages of the disease are characterized by insulin-tissue resistance 
connected with inadequate glucose tolerance. Increased insulin resistance of receptors and 
tissue produces an increased insulin requirement and forces its production in the 
pancreas. If insulin production in the pancreas drops below 50 per cent, a so-called pre-
diabetic condition develops. This is characterized by after-strain hyperglycaemia, also 
called postprandial hyperglycaemia, which often runs sub-clinically. If it remains 
undiagnosed, it can develop into a more advanced form with various tissue and organ 
complications, oral manifestations and complications (Straka, 2011). The most frequent 
oral complications of diabetes are diabetes gingivitis and periodontitis, which are together 
considered to be the seventh most common complication of DM. In type 2 diabetes, the 
incidence of periodontitis is 2.9 – 3.0 times higher than in non-diabetic patients (Nelson et 
al., 1990; Tsai et al., 2002). 
2. Classification of diabetes mellitus 
The present classification of diabetes mellitus uses the AAD (American Association of 
Diabetes) division and distinguishes four types of DM. 
1. Type 1 DM – autoimmune type (older synonym is IDDM – insulin-dependent diabetes 
mellitus), diabetes of young people; 
2. Type 2 DM – non-autoimmune (an older synonym is NIDDM – non-insulin-dependent 
diabetes mellitus), diabetes of adults, insulin non-resistant type; 
3. Specific types of DM 
4. Gestational DM (Straka, 2001; Farkaš et al., 2011). 
3. Etiopathogenesis of DM and diabetic periodontitis 
3.1. Type 1 diabetes mellitus (T1DM) 
T1DM starts as an autoimmune and destructive reaction against the patient’s own 
pancreatic beta-cells. The main risk factor is a genetic predisposition to such an autoimmune 
reaction. Some authors distinguish six stages of T1DM development described as follows: 
the 1st stage, known as genetic predisposition, passes into the 2nd so-called activating stage, 
which is characterized by immediate activation of autoimmune reactions. The 3rd stage, for 
which immune abnormalities are typical, passes into the 4th stage characterized by loss of 
glucose-stimulating insulin production. Clinically present diabetes in the 5th stage is a 
reflection of the large destruction of B-cells and leads to their total destruction in the 6th and 
final stage (Rybka, 1990). In young patients with T1DM, an increased susceptibility to 
gingivitis and periodontitis has been detected. This state is often accompanied by more 
extensive damage to periodontal tissue and an early onset of gingivitis after the patients 
reach the age of 11. Periodontal pockets were detected in 9.8% of a group of young patients 
aged 13 – 18 years, compared with a 1.7% occurrence in a healthy control group (Straka, 
2001; Rybka, 1990). 
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3.1.1. Etiopathogenic and risk factors 
An increased prevalence of gingivitis and periodontitis in adolescents with T1DM is mostly 
attributed to various etiopathogenetic and risk factors of the primary illness:  
Altered immunity. The most frequent immunological disorder is an excessive production of 
the pro-inflammatory cytokines TNF-alpha, IL-1, PGE2 and others. They induce hyper-
inflammatory systemic or local status and contribute to chronicity due to prolonged 
inflammation. The immune system is unable to eliminate significantly gram-negative 
bacteria from the subgingival area. The causes can be genetically determined in a form of 
dangerous phenotype of monocytes/macrophages and their increased inflammatory 
reaction to the LPS toxin as well as various polymorphisms of inflammatory mediators 
(Straka, 2001; Salvi et al. 1997). 
Tissue glycation. Long-lasting hyperglycaemia initiates the rise of so-called non-enzymatic 
tissue glycosylation, which causes formation of AGEs (Advanced Glycosylation End-
products). Increased amounts of AGEs condition a growth of receptors and cause all 
attendant changes in vascular structures and increased formation of inflammatory 
cytokines, adhesive molecules and other immunocompetent substances with possible 
subsequent multiplication of bacterial pathogens (Gislen et al., 1980; Mealey & Oates, 2006; 
Mandell et al, 1992). 
Disorders of tissue regeneration and wound healing. Tissue glycation and expansion of 
inflammation in T1DM patients seem to be a cause of deterioration in the regenerative 
abilities of periodontal tissue, including osseous structures, which are measured by 
means of bone-building biomarkers such as osteocalcin, the values of which were 
reduced in comparison with the control group of non-diabetic patients (Lappin et al., 
2009). 
3.1.2. Influence of T1DM treatment on the state and course of periodontitis 
Several studies report that balanced levels of glycaemia in T1DM patients have a beneficial 
influence on the degree of periodontal tissue damage during periodontitis as well as on its 
clinical course. These results associate total systemic changes with destructive changes to the 
periodontium depending on the therapeutic result of the glycaemia level. The given 
relationship acts reciprocally. (Straka, 2001; Farkaš et al., 2011; Cianciola et al. 1982, Lyons, 
1992) However the results of other present-day clinical studies negate the positive 
correlation between periodontal therapy and its beneficial influence on the course of the 
primary illness. Periodontal therapy in T1DM subjects prevented periodontal infection, but 
did not significantly influence the level of glycated haemoglobin (Tervonen et al., 2009). 
Statistically insignificant results of periodontological therapy on glycated haemoglobin 
concentrations have also been confirmed by another independent study (Lambés et al., 
2008). 
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3.2. Type 2 diabetes mellitus (T2DM) 
The etiopathogenesis of T2DM and its most frequent oral complication are closely 
interconnected. Their mutual associations can be observed in various stages of the primary 
disease. One of the early pathological symptoms of broken homeostasis of glucose is its 
increased postprandial (after-strain) level in the blood. This type of hyperglycaemia is 
bound to food and develops several years before it is clinically manifested by T2DM. The 
pre-diabetic stage of the disease is characterized by the presence of several markers, of 
which the most important is glycated haemoglobin A1c, which represents the amount of 
glycated haemoglobin in erythrocytes (given in percentages). The pre-diabetic stage of the 
disease, measured by means of HB1c, FPG, and 2-hOGTT can be relevant in the 
development of some angiopathies, mainly retinopathy (Ceriello, 2005; Straka, 2011; Rybka, 
1990). In T2DM aetiology as well as in the development of diabetic periodontitis, the 
following groups of factors and mechanisms play crucial roles: 
Genetic associations. For some multifactoral diseases several genes were selected using 
relevant literature gene databases and listed by statistic methods into individual groups 
according to their severity. The most important group is formed by so-called leader genes, 
characteristic for both diseases (Covani et al. 2008). After their application into the databases 
of two leader genes selected from 986 genes for T2DM, four leader genes actively acting in 
both diseases were identified. The most significant of them was NFKB1, whose increased 
activity was detected in periodontal lesions and which seems to have a relationship with 
microvascular defects induced by a systemic inflammatory process. Another leader gene is 
RELA, which together with NFKB1 codes two subunits of the complex NFKB triggering an 
intracellular inflammatory reaction (Covani, Marconcini, Derchi; 2009). STRING software 
enabled us to determine a close association between periodontitis and T2DM by means of 
IL-6 and TNF-alpha (Covani et al., (2009); Nishimuraet al., 2003). It is also true that there are 
certain limitations in the given theoretical knowledge and that by removing these 
limitations, scientific research could more strongly validate the presented knowledge 
(Covani et al., 2009). Nowadays our ability to determine dangerous genetic predispositions 
to T2DM by means of certain genetic profiles, in wide populations, remains considerably 
limited. Genetic risk factors certainly play an important role in the etiopathogenesis of 
T2DM, genome-wide association studies having stated that genetic RF can be useful in 
establishing certain profiles of disease susceptibility and can be used in T2DM disease and 
therapy management (Khoury et al., 2008). 
Insulin resistance. In type 2 diabetes mellitus, there is sufficient insulin at an early stage of the 
disease, a fact confirmed by an abundance of B-cells in pancreatic tissues. But their 
effectiveness in producing insulin varies and is influenced by the progress of the disease, 
level of abdominal obesity and other factors. At the beginning of the disease there is enough 
insulin, but relevant structures are metabolically so altered that biological utilization of 
insulin is insufficient. Insulin in tissues and cells acts by means of its receptors, which are of 
glycoprotein character. A starting signal of cellular activity of insulin is activation by 
receptor tyrosine kinases, which phosphorylate substrates of insulin receptors in tyrosine 
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residues. Glucose transport is ensured by a lipid kinase and is stimulated by P13K into its 
fully active form determined for glucose transport by means of insulin. However these 
mechanisms are extremely complicated and there are several possible ways this complicated 
mechanism of glucose may function. The relationship between insulin and lipogenesis as 
well as the effects of various transcription factors in adipocyte are also very complicated 
(Nishimura et. al., 2003; Kahn & Flier, 2000). Both the prevalence and etiopathogenesis of 
T2DM are nowadays most often associated with obesity, mainly of the abdominal type. 
“Insulin resistance” is not an insulin-induced disorder of glucose metabolism, but an 
expression of decreased insulin-induced transport of glucose and its metabolism in striated 
muscles and adipocytes (Nishimura et al., 2003; Kahn & Flier, 2000; Watanabe et al., 2008; 
Al-Zahrani et al., 2003). Insulin controls glucose homeostasis in the blood, decreasing its 
level by reduced production in liver and increased absorption in muscles and adipose 
tissues. The most frequent disorders of insulin activity are defects of its signal systems, 
mainly in the adipocytes. These require higher effort to get insulin and to produce it in 
larger amounts, which leads to hyperinsulinemia. Excess levels of insulin in the blood can 
result in a receptors imbalance and loss of post-receptor sensitivity; all this can be 
accompanied by glucose intolerance and age-related insufficiency of insulin receptors (Kahn 
& Flier, 2000). Increased serum concentrations of fatty acids (usually connected with 
diabetes and T2DM) contribute to further development of insulin resistance. Excessive levels 
of fatty acids in blood and muscles brake phosphorylation and transport of glucose as well 
as the synthesis of muscular glycogen and subsequent glucose oxidation (Kahn & Flier, 
2000; Ferenčík & Hulín, 2008; Shulman, 2000). 
Metabolic syndrome. Obesity, hyperlipidaemia and insulin resistance are the principal 
symptoms of metabolic syndrome. Obesity also leads to other factors that contribute to 
metabolic syndrome. One of the dominant factors is dyslipidaemia characterized by 
increased triglyceride concentration, non-esterified fatty acids as well as a higher 
concentration of specific LDLs, also called low-density lipoprotein particles. Dyslipidaemia 
is accompanied by low HDL cholesterol levels. Nowadays it is obvious that individual 
components of metabolic syndrome represent independent risk factors in the 
etiopathogenesis of insulin resistance.  Their mutual communicative effect also exists 
(Ferenčík & Hulín, 2008; Shulman, 2000; Coenen et al., 2007). Adipose tissue in obese people 
has various forms. As for formation of pro-inflammatory cytokines, the most harmful is 
white adipose tissue in the abdominal region, which contains residual macrophages (Straka, 
2011; Coenen et al., 2007). Formation of inflammatory cytokines in these macrophages 
significantly increases the pro-inflammatory status of the organism with all its 
consequences. Adipocytes are the principal cells of adipose tissues and are excreted with the 
endocrine function. One of the most important products is leptin characterized by its 
pleiotropic effect, which plays an important role in energy-balance regulation. Adipocytes 
produce substances which have either a direct or indirect relation to insulin resistance. 
Production of pro-inflammatory cytokines and TNF-alpha, IL-6, CRP markers, 
angiotensinogen, but also of steroid hormones of oestrogen and cortisol, contribute to local 
biology of adipose tissue. Increased production of TNF-alpha increases lipolysis and inhibits 
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lipogenesis, which together with other co-factors, leads to insulin resistance (Ferenčík & 
Hulín, 2008; Shulman, 2000; Coenen et al., 2007). 
Inflammation and insulin resistance. Type 2 diabetes, insulin resistance and obesity with 
dyslepidaemia are pro-inflammatory states which are closely interconnected. While leptin 
and adiponektin are exclusively products of adipocytes, TNF-alpha, IL-6, MCP-1, resistin, 
visfatin and PAI-1 are produced by activated macrophages and other cells, and contribute to 
the maintenance and stimulation of low-grade inflammation in obesity (Straka, 2011; 
Shoelson, Jongsoon, Goldifine, 2006). The inflammatory kinases JNK, IKKbeta, PKC, STAT 
cause insulin resistance by decreasing insulin signalization on receptors (Kim et al., 2004; 
Mehta et al., 2010). Nowadays inflammatory cytokines, mainly TNF-alpha, represent 
important etiopathogenic factors of insulin resistance stimulation. Together with the LPS-
toxin of periodontal bacterial pathogens, they activate NF-kapaB, which after displacement 
into the cell nuclei can induce insulin resistance (Ceriello, 2005; Salvi et al. 1997). Patients 
with the abdominal type of obesity show increased TNF-alpha serum levels, which drop 
with decrease of body mass (Gislen et al., 1980). Increased TNF-alpha levels and other pro-
inflammatory mediators circulating in patients with metabolic syndrome can stimulate 
inflammation of the periodontium, where also in clinically healthy individuals, gram-
negative anaerobic bacteria are present, and induce increased proteolytic and osteolytic 
destruction of tissues (Salvi et al., 1997; Mealey & Oates, 2006). Increased prevalence of 
periodontal illnesses in the obese, mainly in younger individuals, has also been confirmed 
by a NHANES III study involving 13,655 patients, who were tested according to periodontal 
indices (PD, AL) and BMI and WC indices. A correlation between these two diseases was 
established by using two different multivariable logistic regressive models containing other 
risk factors in periodontal disorders (sex, race, education, diabetes, smoking habits, date of 
last visit to the dentist) (Mandell et al., 1992). Nowadays the secreting activity of the 
adipocytes of adipose tissues is considered a source of chronic low-grade inflammation as 
well as an important pro-inflammatory etiopathogenetic factor in many serious diseases, 
including type 2 diabetes and inflammatory-destructive illnesses of the periodontium 
(Ceriello, 2005; Lappin, et al., 2009; Lyons, 1992). 
Non-enzymatic glycation. Non-enzymatic glycation presents a basic chemical reaction by 
which glucose is bound to lysine residues and, by means of unstable or stable intermediate 
products, forms so-called advanced glycosylation end products. Production and 
accumulation of AGEs runs also in periodontal tissues and has an influence on their 
composition and immunological qualities in several possible ways. In a normal glycaemic 
regime AGE-receptors are present in small amounts in monocytes, smooth muscle cells, 
neurons, fibroblasts and endothelial cells. Increased levels of AGE-receptors can lead to 
overproduction of adhesive molecules and oxidative elements, the consequence of which is 
an increased uncontrolled anti-inflammatory immune response to the presence of microbial 
pathogens in the periodontium (Tervonen et al., 2009). Another serious factor in a severe 
anti-inflammatory reaction is excessive activity of proteolytic enzymes, which destroy 
periodontal soft tissues. Several studies have confirmed an increased concentration of 
metalloproteinases in the periodontium of a diabetic patient. These are caused by increased 
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transcription of local resident cells stimulated by overproduction of pro-inflammatory 
cytokines (Lambés et al. (2008). Collagen glycation results in strengthening of cross-links 
among its molecules, impairing solubility, natural homeostasis and biological regenerative 
qualities. Regeneration of ageing collagen and basal membrane is reduced and accumulation 
of AGEs products in these structures starts (Covani et al., (2008). Destruction of the 
periodontium correlates with imbalanced glycaemic curve as well as with a level of glycated 
haemoglobin. In diabetic patients with an HbA1c level higher than 8 %, their IL-1beta 
concentration was found to be two times higher than in patients with an HbA1c level lower 
than 8 % (Covani et al., 2009). The level of glycaemic control and length of diabetic disease 
have an impact on the stage of glycation and collagen regeneration in soft and osseous 
tissues. Defects in osteoblast differentiation and altered production of extracellular matrix 
contribute to this state (Cianciola et al., 1982; Nishimura et al., 2003). On the basis of given 
studies we can conclude that the glycation of various components of periodontal tissues 
significantly changes its immunity to various exogene elements (bacteria, viruses) and 
considerably decreases regeneration and healing of these tissues. 
Defects in cell-mediated immunity. In subjects with DM, defects of polymorphonuclear 
leukocytes have been repeatedly confirmed. These are based in defects of chemotaxis and 
phagocytosis and result in insufficient antibacterial protection of periodontal structures 
(McMullen et al., 1981; King, 2008). In subjects with DM, the hypersecretive type of monocytes 
was detected, which on irritation with LPS-endotoxin gram-negative periodontopathic 
bacteria, reacted with increased IL-lbeta and TNF-alpha production, which stimulated 
inflammation of periodontal tissues with excessively destructive osteolysis and tissue 
destruction of periodontal ligaments (Collins et al., 1997; Galbraith et al., 1998). 
Influence of microbial factors. Altered immunity, vasculopathy of periodontal structures, 
decreased solubility of glycated tissues, defects of protein and osseous regeneration and 
repair all cause that immunity of the periodontium to typical periodontal pathogens is 
considerably reduced and is less effective against infections. Some studies report differences 
between groups of patients with long-lasting and correctly managed monitoring of 
glycaemia and those with an insufficiently monitored and managed course of glycaemia. 
Increased amounts of periodontal microbial pathogens were confirmed in diabetic patients 
but their microbial strains were no different from those of non-diabetic patients (Mandel et 
al. 1992; Zambon et al., 1988; Straka, 2011). 
3.3. Gestational DM (GDM) 
Gestational DM is  characterized with high blood sugar levels inpregnant women, who were 
not diagnosed for DM previously. Its prevalencein pregnant women varies from 5 to 7 
percent. Usually is concern atransient form, while placental and maternal adipose tissues 
producehormones which can change metabolism of glucose (Friedlander et al.,2007). Some 
authors state that in up to 50 per cent of women with GDM,T2DM can develop within 3.5 
years. Although there is lack of relevantstudies to this topic and no anonymous conclusion 
was done, most authorsconfirm the hypothesis that pregnant women with GDM have a high 
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risk todevelop a severe form of an inflammatory diseases of the periodont (Novak et 
al.,2006; Friedlander et al., 2007; Xiong, et al., 2006). Thisrelationship runs in both directions 
and presence of inflammatorydiseases unfavorably influences the mother's organism and 
the healthstate of the foetus (Novak et al., 2006; Straka et al., 2011). 
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4. Conclusion  
From the given knowledge we can summarise several theoretical and practical conclusions 
which are important for the diabetological and periodontological management of a patient 
as well as for management of mutual therapeutical associations and procedures: 
Patients with diabetes mellitus have twice or three times a larger incidence of periodontitis. 
This is in relation to significant deterioration of several periodontal parameters such as 
gingivitis, higher prevalence of periodontal pockets, deeper periodontal pockets, higher 
BOP score and loss of attachment. 
Our present state of knowledge defines DM periodontitis as one of the systemic 
complications of diabetes though its main etiopathogenic associations  in cell-altered 
immunity, in glycation of periodontal tissues, vascular damage of the periodontium, 
increased proteolysis and osteolysis of periodontal structures, which result from increased 
concentrations of pro-inflammatory cytokines, deficient regeneration of collagen structures 
and quantitative multiplication of periodontal bacterial pathogens. 
The level of inflammatory destruction of the periodontium is different in patients with a 
good level of control of the primary diabetic disease from patients with insufficient control. 
Changes in periodontal structures can also be detected during the latent stage of diabetes 
and are reflected in unspecified laboratory and clinical findings. 
Nowadays the mutual relationship between these two diseases is considered to run in 
two directions. Local inflammation in the periodontium significantly influences the 
systemic disease due to increased susceptibility of the diabetic patient to infection and 
increased insulin resistance. Deterioration of periodontal parameters and clinical 
manifestations lead to worsening of the diabetic disease. Without reduction of 
inflammation in the periodontium we cannot expect any significant improvement of the 
primary disease.  
In collaboration with a diabetologist, we are trying to diagnose gingivitis and periodontitis 
in the initial stages of diabetes and in detection of the patient’s genetic predisposition to 
diabetic disease.  
During treatment of resistant and refractory types of periodontitis, it is necessary to test 
for diabetic disease, to contact a diabetologist and to try to detect individual pre-diabetic 
states. 
Microbial factors were considerably emphasized in the past. Some studies indicated specific 
subgingival microflora of some strains, namely P. intermedia and strain capnocytophaga 
(Khoury et al., 2008). Our current knowledge, described in several studies, indicates that 
there is no difference in the distribution of individual pathogens in non-diabetic and 
diabetic patients with periodontitis. However patients with DM are afflicted more often by 
repeated infectious diseases (Khoury, et al., 2008). 
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